Altis Biologics (Pty) Ltd is a company specializing in the research and development of osteogenic biomaterials for use in skeletal regeneration therapies in man.

The technological basis underlying the Altis Osteogenic Matrix are the Bone Morphogenetic Proteins (BMPs), a family of growth factors capable of inducing new bone formation commencing within days of implantation into human patients.
Read More ...
Latest News

Altis commissions new Cleanroom facilities at the Innovation Hub in Pretoria South Africa 2013

View gallery

Altis obtains approval from South African medical aid companies for the reimbursement of ALTIS™ Osteogenic Bone Matrix

Altis wins second-place at the South African Breweries Social Entrepreneurship competition 2013

Altis in negotiations with Brazilian distributor seeking agency for Osteogenic Bone Matrix and DBMX products.

Altis relocates to the Innovation Hub in 2012
Altis Biologics Offices

The 2012 Africa SMME Awards will take place on the 27th of September 2012 at the Spier Wine Estate, Stellenbosch
 read more
Altis Biologics secures...

2003- Altis Biologics secures a management contract for the start-up and running of the Centre for Tissue Engineering (CTE)...
 read more
Altis Biologics Awards license...

2004- Altis Biologics awards a license agreement to Osteogenix (Pty) Ltd for Southern Africa for the manufacture
 read more